Sale!

CREBtide – (5-FAM) labeled

Original price was: $1,795.00.Current price is: $895.00.

Catalog Number: B2019504 (1 mg)
CREBtide – (5-FAM) labeled is a peptide associated with CREB, tagged with a fluorescent dye, 5-FAM. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.

Live enquiry about this product via Text/SMS: 1-858-900-3210.

In stock

SKU: B2019504 Categories: , Tag:

Product Description

5/5 - (1 vote)

CREBtide – (5-FAM) labeled
Catalog number: B2019504
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 1 mg
Molecular Weight or Concentration: 1602.6
Supplied as: Powder
Applications: a molecular tool for various biochemical applications
Storage: -20°C
Keywords: Crosstide [GRPRTSpSFAEG], 5-FAM labeled; 5-FAM-GRPRTS-pS-FAEG
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1: Delva-Wiley J, Ekhator ES, Adams LL, Patwardhan S, Dong M, Newman RH. Redox Modification of PKA-Cα Differentially Affects Its Substrate Selection Life (Basel). 2023 Aug 26;13(9):1811.
2: Xiao J, Cai T, Fang Y, Liu R, Flores JJ, Wang W, Gao L, Liu Y, Lu Q, Tang L, Zhang JH, Lu H, Tang J. Activation of GPR40 attenuates neuroinflammation and improves neurological function via PAK4/CREB/KDM6B pathway in an experimental GMH rat model J Neuroinflammation. 2021 Jul 18;18(1):160.
3: Yi F, Cai C, Ruan B, Hao M, Yeo SK, Haas M, Yang F, Zhang X, Guan JL. Regulation of RB1CC1/FIP200 stability and autophagy function by CREBBP-mediated acetylation in an intrinsically disordered region Autophagy. 2023 Jun;19(6):1662-1677.
4: Mezzacappa FM, Smith FK, Zhang W, Gard A, Cabuk FK, Gonzalez-Gomez I, Monforte HL, Liang J, Singh O, Quezado MM, Aldape KD, Gokden M, Bridge JA, Chen J. Potential prognostic determinants for FET::CREB fusion-positive intracranial mesenchymal tumor Acta Neuropathol Commun. 2024 Jan 30;12(1):17.
5: Malik SA, Acharya JD, Mehendale NK, Kamat SS, Ghaskadbi SS. Pterostilbene reverses palmitic acid mediated insulin resistance in HepG2 cells by reducing oxidative stress and triglyceride accumulation Free Radic Res. 2019 Jul;53(7):815-827.
6: Arige V, Terry LE, Malik S, Knebel TR, Wagner Ii LE, Yule DI. CREB regulates the expression of type 1 inositol 1,4,5-trisphosphate receptors J Cell Sci. 2021 Oct 15;134(20):jcs258875.
7: Friedrich MW, Aramuni G, Mank M, Mackinnon JA, Griesbeck O. Imaging CREB activation in living cells J Biol Chem. 2010 Jul 23;285(30):23285-95.
8: Trecourt A, Macagno N, Ngo C, Philip CA, Lopez J, Ferreira J, Alves-Vale C, Ray-Coquard I, Genestie C, Agaimy A, Devouassoux-Shisheboran M. CREB fusion-associated epithelioid mesenchymal neoplasms of the female adnexa: three cases documenting a novel location of an emerging entity and further highlighting an ambiguous misleading immunophenotype Virchows Arch. 2023 Jun;482(6):967-974.
9: Tsunematsu H, Uyeda A, Yamamoto N, Sugo N. Immunocytochemistry and fluorescence imaging efficiently identify individual neurons with CRISPR/Cas9-mediated gene disruption in primary cortical cultures BMC Neurosci. 2017 Aug 1;18(1):55.
10: Shibayama T, Shimoi T, Mori T, Noguchi E, Honma Y, Hijioka S, Yoshida M, Ogawa C, Yonemori K, Yatabe Y, Yoshida A. Cytokeratin-positive Malignant Tumor in the Abdomen With EWSR1/FUS-CREB Fusion: A Clinicopathologic Study of 8 Cases Am J Surg Pathol. 2022 Jan 1;46(1):134-146.

Products Related to CREBtide – (5-FAM) labeled can be found at Substrates

Additional Information

Weight 0.15 oz
Dimensions 2 × 0.5 × 0.5 in
5/5 - (1 vote)

Several ways to order Molecular Depot products:

1- Order online using our website’s automated shopping cart and checkout system (available 24/7).

2- Order by email: info@moleculardepot.com (we accept electronic PO, available 24/7).

3- Order by Live Chat.

4- Order by Fax: 1-858-437-9884 (available 24/7).

Â